drugset / Trial / NCT00771173

CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial

NCT00771173

Phase 4 Completed 258 enrolled Loyola University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of this randomized clinical trial is to compare the utility of phenazopyridine HCl vs. placebo in reducing catheter-associated discomfort during the post-operative period in the gynecologic patient using mean VAS measurments.

Timeline

Start
2008-08
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phenazopyridine Small molecule 200 mg Oral

Indications